Free Trial

Embecta (EMBC) Stock Price, News & Analysis

Embecta logo
$10.47 -0.26 (-2.42%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$10.46 -0.01 (-0.05%)
As of 07/11/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Embecta Stock (NASDAQ:EMBC)

Key Stats

Today's Range
$10.26
$10.65
50-Day Range
$9.28
$13.30
52-Week Range
$9.20
$21.48
Volume
397,140 shs
Average Volume
500,785 shs
Market Capitalization
$611.87 million
P/E Ratio
4.12
Dividend Yield
5.73%
Price Target
$19.33
Consensus Rating
Hold

Company Overview

Embecta Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
95th Percentile Overall Score

EMBC MarketRank™: 

Embecta scored higher than 95% of companies evaluated by MarketBeat, and ranked 58th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Embecta has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Embecta has only been the subject of 2 research reports in the past 90 days.

  • Read more about Embecta's stock forecast and price target.
  • Earnings Growth

    Earnings for Embecta are expected to grow by 7.72% in the coming year, from $2.85 to $3.07 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Embecta is 11.63, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.86.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Embecta is 11.63, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.26.

  • Price to Earnings Growth Ratio

    Embecta has a PEG Ratio of 0.67. PEG Ratios below 1 indicate that a company could be undervalued.

  • Read more about Embecta's valuation and earnings.
  • Percentage of Shares Shorted

    6.84% of the float of Embecta has been sold short.
  • Short Interest Ratio / Days to Cover

    Embecta has a short interest ratio ("days to cover") of 5.8.
  • Change versus previous month

    Short interest in Embecta has recently decreased by 15.84%, indicating that investor sentiment is improving significantly.
  • Dividend Leadership

    Embecta is a leading dividend payer. It pays a dividend yield of 5.73%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Embecta does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Embecta is 66.67%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Embecta will have a dividend payout ratio of 19.54% next year. This indicates that Embecta will be able to sustain or increase its dividend.

  • Read more about Embecta's dividend.
  • Percentage of Shares Shorted

    6.84% of the float of Embecta has been sold short.
  • Short Interest Ratio / Days to Cover

    Embecta has a short interest ratio ("days to cover") of 5.8.
  • Change versus previous month

    Short interest in Embecta has recently decreased by 15.84%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Embecta has a news sentiment score of 1.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.00 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Embecta this week, compared to 4 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Embecta insiders have bought more of their company's stock than they have sold. Specifically, they have bought $106,000.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 0.42% of the stock of Embecta is held by insiders.

  • Percentage Held by Institutions

    93.83% of the stock of Embecta is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Embecta's insider trading history.
Receive EMBC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Embecta and its competitors with MarketBeat's FREE daily newsletter.

EMBC Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
embecta to Participate in Investor Events
See More Headlines

EMBC Stock Analysis - Frequently Asked Questions

Embecta's stock was trading at $20.65 at the start of the year. Since then, EMBC shares have decreased by 49.3% and is now trading at $10.47.

Embecta Corp. (NASDAQ:EMBC) posted its quarterly earnings results on Friday, May, 9th. The company reported $0.70 earnings per share for the quarter, beating analysts' consensus estimates of $0.66 by $0.04. The business's quarterly revenue was down 9.8% on a year-over-year basis.
Read the conference call transcript
.

Shares of EMBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Embecta investors own include Waste Connections (WCN), AU Optronics (AUOTY), The RMR Group (RMR), DiamondRock Hospitality (DRH), American Water Works (AWK), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
5/09/2025
Record date for 6/13 Dividend
5/28/2025
Ex-Dividend for 6/13 Dividend
5/28/2025
Dividend Payable
6/13/2025
Today
7/13/2025
Next Earnings (Estimated)
8/08/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:EMBC
CIK
1872789
Fax
N/A
Employees
2,100
Year Founded
N/A

Price Target and Rating

High Price Target
$25.00
Low Price Target
$13.00
Potential Upside/Downside
+84.7%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.90
Trailing P/E Ratio
11.63
Forward P/E Ratio
3.67
P/E Growth
0.67
Net Income
$78.30 million
Net Margins
4.89%
Pretax Margin
5.10%
Return on Equity
-19.67%
Return on Assets
12.27%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.48
Quick Ratio
1.83

Sales & Book Value

Annual Sales
$1.12 billion
Price / Sales
0.54
Cash Flow
$3.33 per share
Price / Cash Flow
3.14
Book Value
($12.80) per share
Price / Book
-0.82

Miscellaneous

Outstanding Shares
58,440,000
Free Float
58,198,000
Market Cap
$611.87 million
Optionable
Optionable
Beta
1.08
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:EMBC) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners